Riskpilot← Back to searchSign inGet full accessAléxandros AB
ABActiveOrg 5569909814Byvägen 7Medical specialists activities · NACE 8622Est. 20141-4 employees
Revenue 2024
SEK 3,7M
-3% vs 2023
EBITDA margin
23.9%
-12% vs 2023
Equity ratio
64.1%
Financial strength
Net profit 2024
SEK 188K
-70% vs 2023
| Revenue | SEK 3,7M | -3% |
| EBITDA | SEK 879K | -12% |
| Net profit | SEK 188K | -70% |
| Total assets | SEK 1,7M | -22% |
| Equity | SEK 1,1M | -36% |
| Employees | — | — |
Legal name
Aléxandros AB
Org number
5569909814
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 november 2014
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget skall bedriva medicinsk konsultation, medicinsk estetik, utveckling av medicinska IT-applikationer samt därmed förenlig verksamhet.
Address
Byvägen 7
Email
panos@alexandros.nu
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 092 | 3 221 | 3 334 | 3 815 | 3 683 |
| Staff expenses | — | — | −1 872 | — | −2 160 |
| EBITDA | 1 414 | 1 050 | 870 | 1 003 | 879 |
| Depreciation & amort. | −0 | −28 | −72 | −72 | −70 |
| EBIT | 1 414 | 1 022 | 798 | 931 | 808 |
| Net financials | — | −6 | −10 | −200 | −449 |
| Profit before tax | 1 415 | 1 016 | 789 | 830 | 359 |
| Tax | −309 | −216 | −153 | −196 | −170 |
| Net profit | 1 106 | 800 | 636 | 634 | 188 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 107 | 2 267 | 2 243 | 2 229 | 1 745 |
| Equity | 1 330 | 1 644 | 1 770 | 1 735 | 1 119 |
| Long-term debt | 0 | 139 | 0 | 0 | — |
| Short-term debt | 777 | 484 | 473 | 493 | 626 |
| Total debt | 777 | 623 | 473 | 493 | 626 |
EBITDA margin
23.9%
This company
15.8%
Market median
+51% vs market
20202024
Equity ratio
64.1%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
16.8%
This company
18.4%
Market median
+9% vs market
20202024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20202024
Asset turnover
2.11×
This company
1.12×
Market median
+88% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LC Chief Auditor | Chief Auditor | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aléxandros AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lena Christina Normann | Chief Auditor | 0 companies |
| Ann-Christine Maria Sundin | Deputy Board Member | 0 companies |
| Panagiotis Sundin | Board of Directors | 0 companies |